SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Welcome to the POTP board, the DPP-IV company
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: rareearth4210/17/2006 9:45:15 PM
  Read Replies (1) of 90
 
Here we are at just above a dollar a share.

Nothing has fundamentally changed with the company, the two phase 3 trials are recruiting, two phase 2 trials are also underway and it's likely this is another case of the market undervaluing a sparsely traded, poorly followed, microcap biotech.

I recently sold all of my AMLN because I think there's going to be a change in the slope of the Byetta uptake due to Januvia and Galvus and this will be perceived poorly by the market; I'm going to take some of those profits and double my POTP holdings at this level.

I still expect some sort of financing announcement before the end of the year.

RE42
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News